Skip to main content
. 2020 May 15;21(10):3508. doi: 10.3390/ijms21103508

Figure 3.

Figure 3

(A–C): PCNA expression, cell migration and cell viability in myostatin treated VSMCs relative to non-myostatin treated control (100%). (A)—PCNA mRNA expression in myostatin treated VSMCs was downregulated at 10 nM myostatin, but not at 20 nM myostatin, n = 3. (B)—Scratch wound healing in myostatin treated VSMCs was not changed, n = 3. (C)—Cell viability in myostatin treated VSMCs remained unchanged, n = 4. Mean expression is shown and error bars represent SEMs. One-sample t-test performed with 100% of Negative Control expression as control group.